The newly-created blood cells have been transfused in volunteers as part of a study
In what could be termed as a landmark event in the world of medicine and healthcare. A new kind of laboratory grown blood has been brought to the fore. It is being said that lab-grown red blood cells hold the potential to bring in a revolution in the treatment of certain ailments such as sickle cell disease and thalassemia.
The UK-based scientists behind the manufacture of this laboratory-grown blood are confident that it would be a major leap in the field of medical science. The new innovation is now being taken forward with its first clinical trial being conducted.
The newly created blood cells have been transfused in volunteers as part of a study in this regard. The tests are expected to show the way for scientists in learning more about volunteers’ life span and aspects related to compatibility.
Red blood cells developed from stem cells
The new red blood cells have been developed from stem cells taken from donors, said a report quoting scientists behind the innovation. With the studies now on stream, scientists will look forward to the successful transfusion and related events so that they will be able to kick off transfusion process with patients who would need larger amounts of blood in their treatment processes.
The new innovation, depending on the results of the studies being one, is expected to prove to be a major landmark in the manufacture of blood from stem cells. The report added that this is the first-time that laboratory-grown blood from an allogeneic donor was transfused to volunteers. The scientists are now awaiting positive results with regard to the behaviour of the cells when the clinical trial ends.
Results of studies keenly awaited
It has been made known by the scientists that the amount of blood used in these trials stood between 5 and 10 ml, and that they had made sure that the donors were not affected by any kind of ailments.
With the results being keenly awaited, it would mean challenging times for the scientists. And, if the studies prove successful, it would help patients who are currently in need of regular long-term blood transfusions in such a way that they would have to get less number of transfusions in future.
The new lab-grown blood could easily be one of the most significant achievements in the medical arena. The success of the studies would add much confidence in the healthcare terrain in future.
